Skip to search formSkip to main contentSkip to account menu

SC 68896

Known as: SC-68896, SC68896 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Semicarbazones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma
Prognosis remains extremely poor for malignant glioma. Targeted therapeutic approaches, including single agent anti-angiogenic… 
2009
2009
SC68896, a Novel Small Molecule Proteasome Inhibitor, Exerts Antiglioma Activity In vitro and In vivo
Purpose: Glioblastomas are among the most lethal neoplasms, with a median survival of <1 year. Modulation of the proteasome… 
2009
2009
Preclinical Therapy SC 68896 , a Novel Small Molecule Proteasome Inhibitor , Exerts Antiglioma Activity In vitro and In vivo
Purpose: Glioblastomas are among the most lethal neoplasms, with a median survival of <1 year. Modulation of the proteasome… 
2009
2009
Cancer Therapy : Preclinical SC 68896 , a Novel Small Molecule Proteasome Inhibitor , Exerts Antiglioma Activity In vitro and In vivo
Purpose: Glioblastomas are among the most lethal neoplasms, with a median survival of <1 year. Modulation of the proteasome… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)